Conditions

David Levy, MD, FRCP Insulin Pump Treatment (CSII) First used at the end of the 1970s, insulin pump therapy is standard treatment for type 1 diabetes, although use varies between countries (e.g. about 1–2% in the UK, probably more now; about 25% in USA, up to 40% in Norway). Only rapid-acting …

A Columbia Nursing study has found that nurses equipped with a decision support smartphone app using evidence-based guidelines diagnosed more chronic health issues…   Smartphones and tablets may hold the key to getting more nurses to diagnose patients with chronic health issues like obesity, smoking, and depression — three of …

Experts say less sleep affects hormone that controls blood sugar levels… Researchers say lack of sleep can lead to increased levels of substances called free fatty acids in the blood. These substances interfere with the ability of the hormone insulin to regulate blood sugar levels. The researchers said this suggests …

Glucose and fat levels in the blood decreased among obese adults with type 2 diabetes when they exercised after a meal… Jill Kanaley, PhD, of the department of nutrition and exercise physiology at the University of Missouri, said in a press release, “This study shows that it is not just …

A novel insulin that automatically adjusts blood sugar may mitigate some of the complications associated with insulin dosing for patients with type 1 diabetes… Self-administered insulin is the most important therapeutic to provide control over blood glucose levels for patients with type 1 diabetes. However, standard insulin therapy introduces a …

A recent study discovers that there may be an association between breastfeeding and lowering risk of type 1 diabetes… The objective of this study was to determine the association of breast feeding duration with the risk of type 1 diabetes in genetically predisposed newborns. In addition, this study looked at …

High nonesterified fatty acids (NEFAs) show negative relationship to type 2 diabetes. But n-3 fatty acids (FAs) may protect against the disease… Chronically high nonesterified fatty acids (NEFAs) are a marker of metabolic dysfunction and likely increase risk of type 2 diabetes. By comparison, n-3 fatty acids (FAs) have been …

David Levy, MD, FRCP Introduction Insulin treatment in type 1 diabetes is substitution/replacement hormone treatment, but replacement is much more variable and difficult to achieve than in other hormone deficiencies (e.g. thyroid, adrenal, gonadal hormones) because of the minute-by-minute variation in insulin secretion by the intact pancreas, which cannot yet be …

About one and a half years ago I was evaluating the educational needs of a mid-30’s, female, hospital in-patient with diabetes mellitus type 2 (DM2). She and her husband both had DM2. Both were slender, active, did carb counting and followed all the prescribed recommendations of living successfully with diabetes. …

Why is cancer risk higher among diabetes patients?… Evidence indicates an increased risk of certain cancers among people with type 2 diabetes. Evidence for rarer cancers and for type 1 diabetes is limited. Australian researchers recently explored the excess risk of site-specific cancer incidence and mortality among people with type …